Pharmaceutical giant Johnson & Johnson (J&J) (NYSE:JNJ) has announced plans to acquire Intra-Cellular Therapies (NASDAQ:ITCI) ...

A new twist in scamming are text messages that claim you have an unpaid toll and that may try to evade your phone’s security measures. Officials in at least four states — New York, California, ...

Paying US federal and state taxes online can be confusing, and one wrong move can result in penalties or extra money owed. We ...

Study from neutral host providers discovers how Wi-Fi and cellular connectivity have overtaken traditional priorities like price and amenities as top considerations for businesses choosing commercial ...

Johnson & Johnson (J&J) has agreed to pay $132 per share to acquire Intra-Cellular Therapies Inc. in a deal valued at about $14.6 billion, taking ownership of Caplyta (lumateperone), a once-daily oral ...

The latest partnership with U.S. Bank is part of Wisetack's innovative embedded origination program, which has reshaped the bank-fintech relationship model by enabling banks to serve both borrowers ...

U.S. Auto Sales, which had multiple used car dealerships in Georgia, has been ordered by a federal judge to pay more than $42 million.

Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion. The biggest driver was the rights Caplyta which has ...

Shares of Intra-Cellular Therapies are surging 35% in premarket trading Monday after Johnson & Johnson said it will acquire ...

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and ...

MVNOs use big networks but charge less. Here are the top ones and how you can use to stop overpaying major carriers.